International Biotechnology Trust plc
IBT.L · LSE
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Revenue | £19 | £42 | £8 | £22 |
| % Growth | -55.9% | 398.4% | -61.6% | – |
| Cost of Goods Sold | £4 | £2 | £2 | £2 |
| Gross Profit | £14 | £40 | £6 | -£14 |
| % Margin | 77% | 94.8% | 72.6% | -61.3% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £1 | £2 | £1 |
| SG&A Expenses | £0 | £1 | £2 | £1 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £2 | £0 |
| Operating Expenses | £0 | £1 | £4 | £1 |
| Operating Income | -£0 | £40 | £7 | -£17 |
| % Margin | -0.1% | 93.4% | 77.5% | -78% |
| Other Income/Exp. Net | -£1 | -£1 | £0 | -£5 |
| Pre-Tax Income | -£1 | £39 | £7 | -£22 |
| Tax Expense | £0 | £0 | £0 | £0 |
| Net Income | -£1 | £39 | £7 | -£22 |
| % Margin | -6.3% | 91.8% | 80.2% | -101.5% |
| EPS | -0.033 | 1.02 | 0.17 | -0.55 |
| % Growth | -103.2% | 500% | 130.9% | – |
| EPS Diluted | -0.033 | 1.02 | 0.17 | -0.55 |
| Weighted Avg Shares Out | 36 | 38 | 41 | 41 |
| Weighted Avg Shares Out Dil | 36 | 38 | 41 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £2 | £1 | £1 |
| Depreciation & Amortization | £0 | £0 | -£7 | £17 |
| EBITDA | -£0 | £40 | £0 | £0 |
| % Margin | -0.1% | 93.4% | 0% | 0% |